About
Profile
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
SLGL
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Sol-Gel Technologies GAAP EPS of -$0.21 beats by $0.02, revenue of $0.21M misses by $0.48M
- Sol-Gel Technologies GAAP EPS of -$0.24 beats by $0.02
- Israel's Sol-Gel signs Canadian licensing deal for Twyneo, Epsolay
- Sol-Gel Technologies GAAP EPS of -$0.41
- Sol-Gel Technologies GAAP EPS of -$0.65 misses by $0.15, revenue of $3.88M misses by $1.8M
- Sol-Gel to acquire rare disorder drug patidegib for $4.7M upfront; plans $22.8M offerings
- Sol-Gel Technologies GAAP EPS of -$0.15 misses by $0.08, revenue of $0.3M misses by $3.15M
- Sol-Gel Technologies GAAP EPS of $0.01 beats by $0.11, revenue of $3.5M misses by $1.11M
- Sol-Gel Technologies GAAP EPS of -$0.18 beats by $0.11
- Sol-Gel's stock rises as FDA approves Epsolay to treat skin condition rosacea
- Sol-Gel Technologies EPS beats by $0.12, beats on revenue
- Sol-Gel Technologies EPS beats by $0.56, misses on revenue
- Sol-Gel resumes trading, shares rise 8% on approval of Twyneo for acne
- FDA approves Sol-Gel Technologies' TWYNEO to treat acne vulgaris
- Sol-Gel Technologies, Galderma enter license pact for Epsolay and Twyneo; posts pre-clinical data from potential treatments for psoriasis and other dermatological indications (Updated)
- Sol-Gel Technologies EPS beats by $0.63, misses on revenue
- Sol-Gel says no FDA notification regarding its marketing application for EPSOLAY
- Seeking Alpha Catalyst Watch
- Sol-Gel Technologies reports FY 2020 results
- FDA accepts Sol-Gel application for Twyneo
Earnings History
| Date | EPS / Forecast | Revenue / Forecast | |
|---|---|---|---|
| November 11, 2021 | -0.05 / -0.075 | 8.84M / 7.62M |
Beat! |
| August 4, 2021 | -0.35 / -0.215 | 928K / 2.9M |
Beat! |
| May 26, 2021 | - / -0.46 | - / 1.81M | |
| May 13, 2021 | -0.18 / -0.4475 | 701K / 1.67M |
Beat! |
| March 30, 2021 | - / -0.415 | - / 1.59M | |
| March 4, 2021 | -0.28 / -0.285 | 2.1M / 2.1M | |
| November 12, 2020 | -0.37 / -0.46 | 2.12M / 1.82M |
Beat! |
| August 6, 2020 | -0.31 / -0.34 | 1.13M / 3.04M | |
| May 14, 2020 | -0.33 / -0.38 | 3.47M / 3.25M |
Beat! |
| March 24, 2020 | -0.32 / -0.36 | 4.01M / 4.24M | |
| November 13, 2019 | -0.37 / -0.25 | 4.73M / 6.62M | |
| August 13, 2019 | -0.26 / -0.28 | 7.79M / 7M |
Beat! |
| May 22, 2019 | -0.3 / -0.6 | 6.36M / 572K | |
| March 21, 2019 | -0.63 / -0.61 | 129.0K / 0.02M |
Beat! |
| Date | Price | Open | High | Low | Vol | Change | ER | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 17 | 7.49 | 7.21 |
7.49
|
7.21
|
0.86K | 2.39% | ||||
| Mar 16 | 7.31 | 7.38 |
7.45
|
7.21
|
9.35K | -4.07% | ||||
| Mar 15 | 7.62 | 7.62 |
7.62
|
7.48
|
2.45K | 3.39% | ||||
| Mar 14 | 7.37 | 7.55 |
7.58
|
7.37
|
14.42K | -2.38% | ||||
| Mar 11 | 7.55 | 7.48 |
7.62
|
7.25
|
6.73K | 2.10% | ||||
| Mar 10 | 7.39 | 7.21 |
7.48
|
7.21
|
3.29K | -2.57% | ||||
| Mar 9 | 7.59 | 7.49 |
7.59
|
7.35
|
2.81K | 1.34% | ||||
| Mar 8 | 7.49 | 7.24 |
7.49
|
7.16
|
2.64K | 1.35% | ||||
| Mar 7 | 7.39 | 7.15 |
7.48
|
7.14
|
4.73K | 3.36% | ||||
| Mar 4 | 7.15 | 7.23 |
7.29
|
7.01
|
8.54K | -2.46% | ||||
| Mar 3 | 7.33 | 7.05 |
7.34
|
7.05
|
3.12K | 1.81% | ||||
| Mar 2 | 7.20 | 7.28 |
7.35
|
7.13
|
14.99K | -0.41% | ||||
| Mar 1 | 7.23 | 7.42 |
7.42
|
7.23
|
2.67K | -1.63% | ||||
| Feb 28 | 7.35 | 7.19 |
7.35
|
7.19
|
1.96K | 0% | ||||
| Feb 25 | 7.35 | 7.19 |
7.35
|
7.19
|
1.32K | 4.11% | ||||
| Feb 24 | 7.06 | 6.80 |
7.41
|
6.80
|
8.25K | -1.26% | ||||
| Feb 23 | 7.15 | 7.12 |
7.59
|
7.01
|
6.08K | -2.05% | ||||
| Feb 22 | 7.30 | 7.25 |
7.34
|
7.03
|
19.57K | -0.95% | ||||
| Feb 18 | 7.37 | 7.39 |
7.50
|
7.17
|
10.38K | -1.6% | ||||